US measles cases pass 1,750 as Utah-Arizona outbreak grows

The CDC reported 30 new measles cases, bringing the U.S. total to 1,753 this year with 87% outbreak-associated; two-thirds of cases are in those aged 19 or younger, 92% are unvaccinated or have unknown vaccination status, there have been 211 hospitalizations (12% of cases) and three deaths. The largest active outbreak is along the Utah–Arizona border, with Arizona reporting nine new cases for a total of 137 (133 in Mohave County) and Mohave County plus southwestern Utah totaling 201 cases. Public-health concerns are amplified by declining childhood MMR coverage—Minnesota kindergartners are only 86.5% fully vaccinated (well below the 95% herd-immunity threshold), with Idaho the lowest at 78.5%—and Minnesota has recorded 24 cases so far in 2025, its highest in two decades.

Analysis

The CDC reported 30 new measles cases, bringing the U.S. total to 1,753 for the year, with 87% classified as outbreak-associated; two-thirds of cases are in people 19 years and younger and 92% are unvaccinated or have unknown vaccine status, while only 4% of cases had one MMR dose and 4% had two doses. There have been 211 hospitalizations (12% of cases) and three deaths, indicating meaningful clinical burden beyond case counts.

The largest active cluster is along the Utah–Arizona border: Arizona added nine cases to reach 137 (133 in Mohave County), and combined Mohave County plus southwestern Utah account for 201 cases. Minnesota stands out for low kindergarten MMR coverage at 86.5% (well below the 95% herd-immunity threshold), with Idaho at 78.5% and Minnesota recording 24 confirmed cases so far in 2025, the highest in two decades; Minnesota’s pre-pandemic coverage was 92.5%.

Concentration of cases in under-vaccinated children and the 12% hospitalization rate imply continued localized public-health strain and potential for further spread in communities below herd-immunity thresholds. Provided sentiment is moderately negative and the market_impact_score is low (0.12), the immediate macro market effect appears limited; investors should therefore prioritize monitoring local outbreak trajectories, hospitalization trends, and any state-level policy responses rather than assuming broad market disruption.

Key Decisions for Investors

• Monitor CDC updates and state-level case and hospitalization trends (especially Utah–Arizona and Minnesota) for signs of escalation that could affect local healthcare demand
• Reassess exposure to pediatric and community healthcare providers and insurers serving the affected regions given the 12% hospitalization rate and potential for localized capacity stress
• Watch for vaccine policy or procurement announcements from low-coverage states (Idaho, Minnesota, Alaska, Wisconsin) as triggers for changes in vaccine demand or public-health spending
• Avoid broad market positioning on this report given a low market_impact_score; favor targeted, event-driven responses contingent on clear contracting or policy signals